human embryonic stem cell treatment an indian perspective
play

Human Embryonic Stem Cell Treatment An Indian Perspective - PowerPoint PPT Presentation

Mar 04, 2023 •24 likes •804 views

Human Embryonic Stem Cell Treatment An Indian Perspective Presentation by Dr Geeta Shroff 15 March 2013 Kings College, London Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 Kings College, London

  1. Human Embryonic Stem Cell Treatment An Indian Perspective Presentation by Dr Geeta Shroff 15 March 2013 • King’s College, London

  2. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Confession

  3. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Specialist in fertility and IVF techniques

  4. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Five-step process

  5. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective The accident

  6. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective The accident repeated

  7. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Stem cells

  8. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Established stem cell lines

  9. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Regulations and guidelines

  10. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Continuous iteration

  11. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective No ban

  12. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Recommendations may change with time

  13. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Enabling structure

  14. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Product acceptance and release criteria

  15. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective IC-SCRT / NAC-SCRT

  16. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Records, no hype, scientific evidence

  17. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Data for over 1,200 patients

  18. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective GLP, GMP and GCP certifications

  19. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Regulatory environment

  20. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective France

  21. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Germany

  22. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Italy

  23. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective The UK

  24. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective China

  25. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective The USA

  26. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective National Institutes of Health Guidelines on Human Stem Cell Research

  27. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Singapore

  28. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective No specific legislation in Singapore

  29. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Singapore chimeras

  30. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective What have I done differently?

  31. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Only one embryo

  32. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Non-chimeric

  33. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Treatment outcomes

  34. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Assessment standards and scales

  35. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Holistic, sensitive and workable score

  36. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Some cases

  37. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 26-year old male

  38. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 26-year old male 2 June 2011 11 November 2011

  39. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 26-year old male 19 June 2012 16 July 2012

  40. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 26-year old male 2 June 2011 16 July 2012

  41. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 25-year old male

  42. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 25-year old male

  43. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 25-year old male

  44. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 25-year old male Before After

  45. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 46-year old male

  46. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 46-year old male 8 November 2011 3 January 2012

  47. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 46-year old male 7 March 2012 6 November 2012

  48. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 46-year old male 8 November 2011 6 November 2012

  49. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 45-year old female Day 2 Day 10

  50. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 45-year old female Day 19 Day 26

  51. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective 45-year old female Day 1 Day 26

  52. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Ready-to-use form

  53. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective International patent

  54. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Easy clinical application

  55. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Incurable and chronic conditions and illnesses

  56. Presentation by Dr Geeta Shroff Human Embryonic Stem Cell Treatment 15 March 2013 • King’s College, London An Indian Perspective Treatment protocol developed over the years

Recommend

Human Embryonic Stem Cells: Considerations for Therapeutic Product Development Jane Lebkowski

Human Embryonic Stem Cells: Considerations for Therapeutic Product Development Jane Lebkowski

Human Embryonic Stem Cells: Considerations for Therapeutic Product Development Jane Lebkowski Ph.D. Geron Corporation EMA Stem Cell Workshop May 10, 2010 Human Embryonic Stem Cells Large Characterized cGMP Banks Human Embryonic Stem Cells

890 views • 17 slides
Human Embryonic Stem (ES) Cells Human Embryonic Stem (ES) Cells and and Induced Pluripotent

Human Embryonic Stem (ES) Cells Human Embryonic Stem (ES) Cells and and Induced Pluripotent

Human Embryonic Stem (ES) Cells Human Embryonic Stem (ES) Cells and and Induced Pluripotent Stem (iPS) Induced Pluripotent Stem (iPS) Cells Cells Junying Yu Yu Junying What is a Cell? What is a Cell? DNA Nucleus Cytoplasm Cells

239 views • 21 slides
Client Alert Stem Cell Therapy in 2009: From Lab to Market Contact Attorneys Regarding This

Client Alert Stem Cell Therapy in 2009: From Lab to Market Contact Attorneys Regarding This

Client Alert Stem Cell Therapy in 2009: From Lab to Market Contact Attorneys Regarding This Matter: Stem cell therapy has the potential to change dramatically the treatment of Clark G. Sullivan human disease. A number of adult stem cell

616 views • 3 slides
stem cells in defined conditions Ludwig et al. 2006 Robert Warren, Age 20 TBI in War in

stem cells in defined conditions Ludwig et al. 2006 Robert Warren, Age 20 TBI in War in

Derivation of human embryonic stem cells in defined conditions Ludwig et al. 2006 Robert Warren, Age 20 TBI in War in Afghanistan EzineMark.com 07/22/11 The Promise of Stem Cells What are Stem Cells? Multipotent or Pluripotent Cell Types

738 views • 37 slides
Cell Commitment and Epigenetic Memory Reprogramming Embryonic stem cells Lineage potential

Cell Commitment and Epigenetic Memory Reprogramming Embryonic stem cells Lineage potential

Cell Commitment and Epigenetic Memory Reprogramming Embryonic stem cells Lineage potential Differentiation Progenitor cells Transdetermination De-differentiation Specialised cells Transdifferentiation Lymphocyte Reprogramming strategies

426 views • 13 slides
Two discoveries that will shape the 21st century Deciphering the Human Genome Lifebook.dat

Two discoveries that will shape the 21st century Deciphering the Human Genome Lifebook.dat

Two discoveries that will shape the 21st century Deciphering the Human Genome Lifebook.dat the database required to make a human being Production of Human Embryonic Stem Cell Lines Formlife.exe the executable program to make a human

594 views • 23 slides
Embryonic Stem Cells: Embryonic Stem Cells: The Mouse Source vehicle vehicle The Mouse

Embryonic Stem Cells: Embryonic Stem Cells: The Mouse Source vehicle vehicle The Mouse

Nobel Lecture in Physiology or Medicine Embryonic Stem Cells: Embryonic Stem Cells: The Mouse Source vehicle vehicle The Mouse Source for Mammalian Genetics for Mammalian Genetics Martin Evans Martin Evans School of Biosciences

692 views • 37 slides
Treatment of HIV and EBV associated lymphoma by allogenic CCR5 32 blood stem cell

Treatment of HIV and EBV associated lymphoma by allogenic CCR5 32 blood stem cell

Treatment of HIV and EBV associated lymphoma by allogenic CCR5 32 blood stem cell transplantation AREVIR-Meeting 2019 - Viral load below detection limit what is next Marek Widera The 1 st Essener Patient Folie 2 Titel Treatment of HIV and

162 views • 12 slides
Biological properties and enucleation enucleation of of red red Biological properties and blood

Biological properties and enucleation enucleation of of red red Biological properties and blood

Biological properties and enucleation enucleation of of red red Biological properties and blood cells from from human embryonic stem cells human embryonic stem cells blood cells Shi-Jiang Lu, Qiang Feng, Jennifer S. Park, Loyda Vida, Bao-Shiang

230 views • 20 slides
12/21/10 STEM CELLS - BASIC CONCEPTS WHAT IS A STEM CELL? A cell that can undergo self-renewing

12/21/10 STEM CELLS - BASIC CONCEPTS WHAT IS A STEM CELL? A cell that can undergo self-renewing

12/21/10 STEM CELLS - BASIC CONCEPTS WHAT IS A STEM CELL? A cell that can undergo self-renewing (expanding) proliferation Joel C. Glover and give rise to specialized differentiated cells Norwegian Center for Stem Cell Research CAST Laboratory

305 views • 8 slides
Human Pluripotent Stem Cell Research for Regenerative Medicine and Drug Discovery Our

Human Pluripotent Stem Cell Research for Regenerative Medicine and Drug Discovery Our

Human Pluripotent Stem Cell Research for Regenerative Medicine and Drug Discovery Our Multidisciplinary Academia-Industry Collaboration Project in Japan Norio Nakatsuji Professor and Founding Director Institute for Integrated Cell-Material

397 views • 26 slides
Narsoplimab (OMS721) For the Treatment of Adult Hematopoietic Stem Cell Transplant- associated

Narsoplimab (OMS721) For the Treatment of Adult Hematopoietic Stem Cell Transplant- associated

Narsoplimab (OMS721) For the Treatment of Adult Hematopoietic Stem Cell Transplant- associated Thrombotic Microangiopathy Alessandro Rambaldi, MD Department of Oncology and Hematology, University of Milan and ASST Papa Giovanni XXIII, Bergamo,

386 views • 20 slides
What are Stem Cells? How can they be used in medicine? What is a stem cell????........ What is a

What are Stem Cells? How can they be used in medicine? What is a stem cell????........ What is a

What are Stem Cells? How can they be used in medicine? What is a stem cell????........ What is a stem cell????........ .....a cell with the ability to differentiate into specialized cells and renew to become more stem cells THE BUILDING BLOCKS

383 views • 16 slides
MODELING EMBRYONIC PERIODICITY by Jasmine Hamdan Based on Models for Embryonic

MODELING EMBRYONIC PERIODICITY by Jasmine Hamdan Based on Models for Embryonic

MODELING EMBRYONIC PERIODICITY by Jasmine Hamdan Based on Models for Embryonic Periodicity by L.I. Held, Jr. OUTLINE Regularity vs. Perdiodicity Modeling Mechanisms Positional Information Rearrangement Cell lineage

542 views • 19 slides
The New York Stem Cell Foundation Accelerating Cures Through Stem Cell Research New York Pharma

The New York Stem Cell Foundation Accelerating Cures Through Stem Cell Research New York Pharma

The New York Stem Cell Foundation Accelerating Cures Through Stem Cell Research New York Pharma Forum Susan Solomon December 6, 2013 Stem Cell Research in the United States 1996 Dickey Wicker Amendment 1998 James Thompson and

691 views • 33 slides
LUMESE PRO LAB NO.1 Stem Cell Activation Treatment for Aging Skin INTRODUCTION With age,

LUMESE PRO LAB NO.1 Stem Cell Activation Treatment for Aging Skin INTRODUCTION With age,

LUMESE PRO LAB NO.1 Stem Cell Activation Treatment for Aging Skin INTRODUCTION With age, our skin becomes more fragile and thin, making the most common signs of aging fine lines, wrinkles, loss of elasticity, sagging skin and

1.46k views • 20 slides
Overview of Regulation of Stem Cell-Based Products by the U.S. FDA EMA Stem Cell Workshop 10

Overview of Regulation of Stem Cell-Based Products by the U.S. FDA EMA Stem Cell Workshop 10

Overview of Regulation of Stem Cell-Based Products by the U.S. FDA EMA Stem Cell Workshop 10 May 2010 Kimberly Benton, Ph.D. Deputy Director Division of Cellular and Gene Therapies FDA/CBER/OCTGT 1 FDA Organization CBER (Center for

609 views • 25 slides
Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell

Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell

Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell transplantation Elena Knops Elena Knops, AREVIR, Cologne 2017 Background - the Berlin patient so far the only person presumed to be cured from HIV by

632 views • 32 slides
Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell

Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell

Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell transplantation Elena Knops Elena Knops, GfV 2016 Background - the Berlin patient so far the only person presumed to be cured from HIV by hematopoietic

398 views • 25 slides
Germ cells production from established goat embryonic stem cells and iPS cells Dhruba Malakar*,

Germ cells production from established goat embryonic stem cells and iPS cells Dhruba Malakar*,

1 Germ cells production from established goat embryonic stem cells and iPS cells Dhruba Malakar*, Hruda Nanda Malik and Dinesh Kumar Animal Biotechnology Centre, National Dairy Research Institute, Karnal-132001, India *Corresponding author.

320 views • 12 slides
Reflection paper on stem cell based medicinal products - introduction Workshop on stem cell

Reflection paper on stem cell based medicinal products - introduction Workshop on stem cell

Reflection paper on stem cell based medicinal products - introduction Workshop on stem cell based therapies EMA 10 May 2010 Dr Tiina Palomki Finnish medicines agency Regulatory framework - need for additional guidance Directive

220 views • 17 slides
Therapeutic and Research Potential of Human Stem Cells Prospects and Challenges Dr Stephen

Therapeutic and Research Potential of Human Stem Cells Prospects and Challenges Dr Stephen

Therapeutic and Research Potential of Human Stem Cells Prospects and Challenges Dr Stephen L Minger Dr Stephen L Minger Stem Cell Biology Laboratory Stem Cell Biology Laboratory Wolfson Centre for Age- -Related Diseases Related

582 views • 37 slides
INTRODUCING SIMULATED STEM CELLS INTO A BIO-INSPIRED CELL- CELL COMMUNICATION MECHANISM FOR

INTRODUCING SIMULATED STEM CELLS INTO A BIO-INSPIRED CELL- CELL COMMUNICATION MECHANISM FOR

INTRODUCING SIMULATED STEM CELLS INTO A BIO-INSPIRED CELL- CELL COMMUNICATION MECHANISM FOR STRUCTURE REGENERATION GIORDANO FERREIRA 1 , MATTHIAS SCHEUTZ 1 , MIKE LEVIN 2 GIORDANO.FERREIRA@TUFTS.EDU 1 HUMAN ROBOT INTERACTION LABORATORY AT TUFTS

1.04k views • 22 slides
Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell

Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell

Treatment of HIV and acute myeloid leukemia by allogeneic CCR5-d32 blood stem cell transplantation Elena Knops / Bjrn Jensen AREVIR, Cologne 2018 Chapter I .... .... one week before SCT AREVIR, Cologne 2018 Chapter II June 2013 total

378 views • 36 slides

More recommend